Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10Sep 17, 2024
Expansion
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Benedikt von Braunmühl; Tom Roberts
Rentschler Biopharma SE
PAO-09-24-CL-05Sep 09, 2024
M&A
Olon Continues its Growth Path and Announces a New Acquistion
Olon
PR-09-24-NI-01Sep 04, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04Sep 04, 2024
Minitablets
Minitablets: Enhancing Safety and Palatability for Pediatric Medicines
Gus LaBella
Mikart
PAO-09-24-CL-01Aug 30, 2024
Comparability
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Pawel Stanczak, Ph.D.; Xuemei Han, Ph.D.; Miguel Carrion
Tanvex CDMO
PAO-07-24-CL-08Aug 26, 2024
Digitalization
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Michael Sokolov, Ph.D.
DataHow
PAO-08-24-CL-02Aug 26, 2024
Developability
Assessing Developability and Designing Advanceable Formulations from the Start
Nazar Elkarim, Ph.D.
Mikart
PAO-09-24-CL-02Aug 26, 2024
IND Enablement
IND Enablement and Drug Product Development – Mitigating Risk and Accelerating through the "Valley of Death"
Johannes Clemens
Coriolis Pharma
PAO-08-24-CL-07Aug 16, 2024
Capacity Expansion
CiVentiChem Increases Capacity by 300% with New Facility; Celebrates 30th Anniversary
CiVentiChem
PR-08-24-NI-02Aug 13, 2024
Sequence Variants
Accelerating Protein Sequence Variant Analysis
Kyoungmin Lee; Yunjeong Heo; Jongbae Park
Samsung Biologics
PAO-08-24-CL-08Aug 13, 2024
CEO Appointment
Bio X Cell Announces CEO Appointment
Bio X Cell
PR-08-24-NI-01Aug 12, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02Aug 07, 2024
Developability
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Andrea Hawe
Coriolis Pharma
PAO-07-24-CL-11Aug 01, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04Jul 29, 2024
Regulatory
Building a Path to Approval with Effective Regulatory Support
Mira Han
Samsung Biologics
PAO-07-24-CL-12Jul 29, 2024
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03Jul 22, 2024
CRDO
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
Silvia Steyrer-Gruber
Coriolis Pharma
PAO-07-24-CL-05Jul 16, 2024
Liquid Suspensions
Beyond Pills: the Rise of Liquid Suspensions for Complex Formulations
Gus LaBella
Mikart
PAO-07-24-CL-04Jul 09, 2024